重组凝血因子VIIa用于循环辅助装置患者的顽固性危及生命的出血 - Suppr

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.

作者信息

Schneider Antoine G, Perez Marie-Hélène, Tozzi Piergiorgio, Voirol Pierre, Schoettker Patrick, Angelillo-Scherrer Anne, Cotting Jacques, Von Segesser Ludwig, Eggimann Philippe

出版信息

Intensive Care Med. 2010 Sep;36(9):1620-1. doi: 10.1007/s00134-010-1937-y. Epub 2010 Jun 3.

DOI:10.1007/s00134-010-1937-y

PMID:20521024

Abstract

摘要

相似文献

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.重组凝血因子VIIa用于循环辅助装置患者的顽固性危及生命的出血

Intensive Care Med. 2010 Sep;36(9):1620-1. doi: 10.1007/s00134-010-1937-y. Epub 2010 Jun 3.

Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).重组活化因子 VII 在心血管手术后难治性出血中的超适应证使用：23 家法国心脏中心实践的观察性研究（2005-2007 年）。

Eur J Cardiothorac Surg. 2011 Dec;40(6):1320-7. doi: 10.1016/j.ejcts.2011.03.032. Epub 2011 May 6.

Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.在高危心脏手术中使用重组 VIIa 因子（诺和诺德因子 VIIa RT）。

Eur J Cardiothorac Surg. 2011 Dec;40(6):1314-8; discussion 1318-9. doi: 10.1016/j.ejcts.2011.03.048. Epub 2011 May 20.

Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia A and inhibitor--clinical outcome and laboratory observations.血小板输注辅助重组凝血因子VIIa治疗重度甲型血友病伴抑制剂患者——临床结果及实验室观察

Thromb Haemost. 2010 Jun;103(6):1275-6. doi: 10.1160/TH10-01-0019. Epub 2010 Apr 29.

Pediatric off-label use of recombinant factor VIIa.重组凝血因子VIIa在儿科的超说明书用药

Pediatrics. 2009 Mar;123(3):1066-72. doi: 10.1542/peds.2008-1685.

Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.低剂量重组活化凝血因子VII（诺其）治疗心脏手术后难治性出血：一项倾向评分分析

Eur J Cardiothorac Surg. 2008 Jan;33(1):64-71. doi: 10.1016/j.ejcts.2007.10.004. Epub 2007 Nov 8.

Recombinant factor VIIa plus surgery for intracerebral hemorrhage.重组凝血因子VIIa联合手术治疗脑出血

Can J Neurol Sci. 2008 Nov;35(5):567-72. doi: 10.1017/s0317167100009343.

Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.血管损伤与血栓形成倾向：关于重组凝血因子VIIa的一则警示

Semin Cardiothorac Vasc Anesth. 2007 Dec;11(4):261-4. doi: 10.1177/1089253207311357.

Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.低剂量重组凝血因子VIIa用于心脏手术患者术后无法控制的出血管理

J Cardiothorac Vasc Anesth. 2006 Aug;20(4):573-5. doi: 10.1053/j.jvca.2005.06.005. Epub 2006 Jan 18.

Postoperative hemorrhage secondary to acquired hemophilia A.获得性甲型血友病继发的术后出血

JAAPA. 2020 Jun;33(6):24-26. doi: 10.1097/01.JAA.0000660136.56989.ef.

引用本文的文献

Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review.重组凝血因子VIIa用于体外膜肺氧合患者的难治性出血：15例报告及文献复习

Crit Care. 2013 Mar 25;17(2):R55. doi: 10.1186/cc12581.

Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).体外生命支持（ECLS）患者获得性 von Willebrand 综合征。

Intensive Care Med. 2012 Jan;38(1):62-8. doi: 10.1007/s00134-011-2370-6. Epub 2011 Oct 1.

本文引用的文献

Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery.加拿大对重组活化因子VII在心脏手术中未标明用途的全面审查。

Circulation. 2008 Jul 22;118(4):331-8. doi: 10.1161/CIRCULATIONAHA.108.764308. Epub 2008 Jul 7.

Guideline on antiplatelet and anticoagulation management in cardiac surgery.心脏手术抗血小板及抗凝管理指南

Eur J Cardiothorac Surg. 2008 Jul;34(1):73-92. doi: 10.1016/j.ejcts.2008.02.024. Epub 2008 Mar 28.

rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.重组活化凝血因子VII（rFVIIa）用于治疗先天性心脏病手术后接受体外膜肺氧合（ECMO）的儿科患者的持续性出血。

Paediatr Anaesth. 2007 Dec;17(12):1176-81. doi: 10.1111/j.1460-9592.2007.02328.x.

Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.活化重组因子VII在心室辅助装置或原位心脏移植后严重凝血病中的应用。

J Cardiothorac Surg. 2007 Jul 6;2:32. doi: 10.1186/1749-8090-2-32.

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.重组凝血因子VII治疗新生儿及小儿心脏手术后出血

Ann Thorac Surg. 2007 Jul;84(1):161-8. doi: 10.1016/j.athoracsur.2007.02.051.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献